These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1929099)

  • 21. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised double-blind trial of the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis.
    Khajehei M; Keshavarz T; Tabatabaee HR
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):525-30. PubMed ID: 19780738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
    Koloszár S; Kovács L
    Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia.
    Pagano R; Wong S
    J Low Genit Tract Dis; 2012 Oct; 16(4):394-7. PubMed ID: 22622338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and tolerance of veralipride in the treatment of flushing in the menopause. A multicenter study].
    Boukobza G
    Rev Fr Gynecol Obstet; 1986 Sep; 81(8):413-7. PubMed ID: 3532280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment.
    Blum M
    Clin Exp Obstet Gynecol; 1985; 12(1-2):1-2. PubMed ID: 3987021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful hormonal therapy of climacteric disorders].
    Täger F
    Fortschr Med; 1980 Jul; 98(26-27):1036-8. PubMed ID: 7429389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
    Quereux C; Ezes H; Deltour G; Decaux J; Dorangeon P; Wahl P
    Sem Hop; 1980 Oct; 56(37-38):1453-9. PubMed ID: 6254160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transvaginal administration of estriol in postmenopausal urogynecological disorders].
    Di Stefano L; Patacchiola F; Moscarini M
    Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.